A Study of Decreased Dose Frequency in Participants With Systemic Juvenile Arthritis Who Experience Laboratory Abnormalities During Treatment With RoActemra/Actemra (Tocilizumab)
Clinical trial NCT01734382 · COMPLETED
Trial details
- NCT number
- NCT01734382
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-10
- Primary completion
- 2019-10-09
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.